Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study

The optimal duration of firstline chemotherapy in metastatic esophagogastric cancer is unknown. In most clinical trials therapy was given until tumour progression or limiting toxicity. | Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer the multinational MATEO study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN